SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
about
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinomaZoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaGene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis.A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma.Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.[The Role of SOCS in the Development of Tumors].
P2860
Q33589279-EC53E46B-DE4D-4826-B5AB-E1CA34192454Q33648638-3E86C241-77D6-40E7-A698-C695D894F468Q35176037-EC2C8F9A-4E7F-417C-93BB-2188265B63F3Q35909650-42ACABB4-578D-4577-8765-6F15E8C58387Q37703404-7182F94D-D615-444F-A0C5-ADD5CA241B29Q38806938-26AE5E14-4104-4A05-B51B-29D9FF23E098Q38853116-172F261E-1DE6-496D-B5D1-89035DAE35A9Q38994020-77F12036-02BC-49C5-A2B2-C830ADC3CE00Q39073167-308CA9F5-5D81-4C60-80AB-218351C6A6B3Q39107722-290EA84A-471D-4293-8C96-A1B7ADA23E72Q48144099-19F8901A-5D54-49F0-80CA-EBCDF075436AQ52714599-098A4C95-BA2D-4644-9608-DCAC1FF6CD72Q55492703-B2B8C274-AA78-4B78-8742-F76EE468F3C0
P2860
SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@en
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@nl
type
label
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@en
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@nl
prefLabel
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@en
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@nl
P2093
P2860
P356
P1476
SOCS-1 gene delivery cooperate ...... alignant pleural mesothelioma.
@en
P2093
Barry Ripley
Hiroyuki Mizuguchi
Ichiro Kawase
Kazuki Shimada
Kota Iwahori
Minoru Fujimoto
Satoshi Serada
Shintaro Nomura
Tadamitsu Kishimoto
Tetsuji Naka
P2860
P304
P356
10.1002/IJC.27611
P577
2012-05-17T00:00:00Z